Skip to main content

Therapeutic areas

Our therapies are concentrated within the areas of haematology, immunology and specialty care.

Within haematology we provide extended half-life recombinant replacement clotting factor treatments for haemophilia A and haemophilia B, and a treatment for thrombocytopenia, a condition characterised by abnormally low levels of platelets in the blood.

The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years. Our Immunology portfolio allows the treatment of serious, disabling or even life-threatening diseases.

We also provide important specialty treatments in the area of genetics and metabolism.

Haematology

The area of haematology covers a wide range of conditions, including those involving red and white blood cells, coagulation and platelets, and bone marrow.

Immunology

The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.

Specialty Care

We provide products for the treatment of genetic and metabolic diseases as well as a number of specialist indications.

Development Pipeline

We see innovation as essential to our vision of being a global leader in rare diseases. We need to reinvest in research and development to continue to provide innovative treatments.